Skip to main content
SpringerLink
Log in

Contraception for Women with Mental Health Conditions

  • Chapter
  • First Online:
Contraception for the Medically Challenging Patient

Abstract

Mental health disorders, which are among the most prevalent chronic diseases affecting reproductive-aged women worldwide, can have adverse reproductive health consequences, including increased risk of unintended pregnancy. Contraception can play an important role in the health and well-being of women with depression, anxiety, and other serious mental illness. In this chapter, we describe contraceptive considerations for women with mental health conditions. We emphasize the most common mental health conditions, including depression and anxiety (Part I), but also discuss other serious mental illnesses (Part II). We address the potential effects of contraception on mental health and vice versa, contraceptive method effectiveness and adherence concerns, mental health-specific contraceptive method safety and drug considerations, clinically relevant counseling and management strategies, and ethical issues for reproductive autonomy and contraceptive decision-making for women with mental health conditions. Throughout, we note important gaps in scientific knowledge and areas for future research on mental health and contraception. Our goal is to offer a reference for health providers who care for women with mental health conditions wishing to avoid an unintended pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. U.S. Department of Health and Human Services’ Office on Women’s Health; Substance Abuse and Mental Health Services Administration. Action Steps for Improving Women’s Mental Health. 2009. Author.

    Google Scholar 

  2. U.S. Department of Health and Human Services. Mental Health. Healthy People 2020. http://www.healthypeople.gov/2020/LHI/mentalHealth.aspx. Accessed 27 Sept 2013.

  3. World Health Organization. The World Health Report 2001, Mental Health: New Understanding, New Hope. 2001. Geneva, Switzerland: World Health Organization; 2001.

    Google Scholar 

  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revised. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  5. Gore FM, Bloem PJN, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10–24 years: a systematic analysis. Lancet. 2011;377:2093–102.

    PubMed  Google Scholar 

  6. WHO. The global burden of disease: 2004 update 2008. Geneva, Switzerland: WHO; 2008.

    Google Scholar 

  7. Kessler RC. Epidemiology of women and depression. J Affect Disord. 2003;74(1):5–13.

    PubMed  Google Scholar 

  8. Harvard Medical School. National Comorbidity Survey. 2009. http://www.hcp.med.harvard.edu/ncs/index.php. Accessed 27 Sept 2013.

  9. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.

    PubMed  Google Scholar 

  10. Twenge JM, Gentile B, DeWall N, Ma D, Lacefield K, Schurtz DR. Birth cohort increases in psychopathology among young Americans, 1938–2007: a cross-temporal meta-analysis of the MMPI. Clin Psychol Rev. 2010;30(2):145–54.

    PubMed  Google Scholar 

  11. Cross-National Collaborative Group. The changing rate of major depression. Cross-national comparisons. JAMA. 1992;268(21):3098–105.

    Google Scholar 

  12. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and substance use disorders in the United States between 1991–1992 and 2001–2002. Am J Psychiatry. 2006;163(12):2141–7.

    PubMed  Google Scholar 

  13. National Institute of Mental Health [internet]. Use of mental health services and treatment among adults. http://www.nimh.nih.gov/statistics/3USE_MT_ADULT.shtml. Accessed 24 Oct 2012.

  14. National Institute of Mental Health [internet]. Use of mental health services and treatment among children. http://www.nimh.nih.gov/statistics/1NHANES.shtml. Accessed 24 Oct 2012.

  15. Barrio L, Burt V. Depression in pregnancy: strategies for primary care management. Dealing with under-diagnosed and undertreated problem. Wom Health Prim Care. 2000;3:490.

    Google Scholar 

  16. Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290:57–65.

    PubMed  Google Scholar 

  17. Farr SL, Dietz PM, Williams JR, Gibbs FA, Tregear S. Depression screening and treatment among non-pregnant women of reproductive age in the United States, 1990–2010. Prev Chron Dis. 2011;8:A122.

    Google Scholar 

  18. Li-Ching L, Casanueva CE, Martin SL. Depression among female family planning patients: prevalence, risk factors and use of mental health services. J Womens Health. 2005;14:225–32.

    Google Scholar 

  19. Ko JY, Farr SL, Dietz PM, Robbins CL. Depression and treatment among US pregnant and non-pregnant women of reproductive age, 2005–2009. J Womens Health. 2012;21:830–6.

    Google Scholar 

  20. Dennis CL, Ross LE, Grigoriadis S. Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database Syst Rev. 2007;3. Art. No.: CD006309. DOI: 10.1002/14651858.CD006309.pub2.

  21. Farr SL, Bitsko RH, Hayes DK, Dietz PM. Mental health and access to services among US women of reproductive aged. Am J Obstet Gynecol. 2010;203:e1–9.

    PubMed  Google Scholar 

  22. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve month use of mental health services in the United States. Arch Gen Psychiatry. 2005;62:629–40.

    PubMed  Google Scholar 

  23. Carrington CH. Clinical depression in African American women: diagnosis, treatment and research. J Clin Psychol. 2006;62:779–91.

    PubMed  Google Scholar 

  24. Das AK, Ofson M, McCurtis HL, Weissman MM. Depression in African Americans: breaking barriers to detection and treatment. J Fam Pract. 2006;55:30–9.

    PubMed  Google Scholar 

  25. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–6.

    PubMed  Google Scholar 

  26. American Psychological Association [internet]. Women and depression. http://www.apa.org/about/gr/issues/women/depression.aspx. Accessed 24 Oct 2012.

  27. Mcleod JD, Kessler RC. Socioeconomic status differences in vulnerability to undesired life events. J Health Soc Behav. 1990;31:162–72.

    CAS  PubMed  Google Scholar 

  28. U.S. Department of Health and Human Services. Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Rockville, MD: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.

    Google Scholar 

  29. Frost JJ, Singh S, Finer LB. Factors associated with contraceptive use and nonuse, United States, 2004. Perspect Sex Reprod Health. 2007;39(1):48–55.

    PubMed  Google Scholar 

  30. Gee RE, Mitra N, Wan F, Chavkin DE, Long JA. Power over parity: intimate partner violence and issues of fertility control. Am J Obstet Gynecol. 2009;201(148):e1–7.

    PubMed  Google Scholar 

  31. Miller E, Decker MR, McCauley HL, Tancredi DJ, Levenson RR, Waldman J, et al. Pregnancy coercion, intimate partner violence and unintended pregnancy. Contraception. 2010;81(4):316–22.

    PubMed Central  PubMed  Google Scholar 

  32. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of pre-term birth, low birth weight and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67:1012–24.

    PubMed Central  PubMed  Google Scholar 

  33. Flynn HA, Walton MA, Chermack ST, Cunningham RM, Marcus SM. Brief detection and co-occurrence of violence, depression and alcohol risk in prenatal care settings. Arch Womens Ment Health. 2007;10:155–61.

    CAS  PubMed  Google Scholar 

  34. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor the obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 2007;20:189–209.

    PubMed  Google Scholar 

  35. Kelly RH, Russo J, Holt V, Danielsen BH, Zatzick DF, Walker E, et al. Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery. Obstet Gynecol. 2002;100:297–304.

    PubMed  Google Scholar 

  36. Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008;65:805–15.

    PubMed Central  PubMed  Google Scholar 

  37. Williams KE, Marsh WK, Rasgon NL. Mood disorders and fertility in women: a critical review of the literature and implications for future research. Hum Reprod Update. 2007;13:607–16.

    PubMed  Google Scholar 

  38. Bennett IM, Culhane JF, McColuum KF, Elo IT. Unintended rapid repeat pregnancy and low education status: any role for depression and contraceptive use? Obstet Gynecol. 2006;194:749–54.

    Google Scholar 

  39. Steinberg JR, Trussell J, Hall KS, Guthrie K. Fatal flaws in a recent meta-analysis on abortion and mental health. Contraception. 2012;86(5):4307.

    Google Scholar 

  40. Takahashi S, Tsuchiya KJ, Matsumoto K, Suzuki K, Mori N, Takei N. Psychosocial determinants of mistimed and unwanted pregnancy: the Hamamatsu Birth Cohort Study. Matern Child Health J. 2012;16(5):947–55.

    PubMed  Google Scholar 

  41. Steinberg JR, Becker D, Henderson JT. Does the outcome of a first pregnancy predict depression, suicidal ideation, or lower self-esteem? Data from the National Comorbidity Survey. Am J Orthopsychiatry. 2011;81(2):193–201.

    PubMed Central  PubMed  Google Scholar 

  42. Steinberg JR, Finer LB. Examining the association of abortion history and current mental health: a reanalysis of the National Comorbidity Survey using a common-risk-factors model. Soc Sci Med. 2011;72:72–82.

    PubMed  Google Scholar 

  43. Kessler RC, Berglund PA, Foster CL, Saunders WB, Stang PE. Walters EE Social consequences of psychiatric disorders. II: Teenage parenthood. Am J Psychiatry. 1997;154(10):1405–11.

    CAS  PubMed  Google Scholar 

  44. Lancaster CA, Gold KJ, Flynn HA, Yoo H, Marcus SM, Davis MM. Risk factors for depressive symptoms during pregnancy: a systematic review. Am J Obstet Gynecol. 2010;205(3):5–14.

    Google Scholar 

  45. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106(5):1071–83.

    PubMed  Google Scholar 

  46. Marcus S, Flynn H, Blow F, Barry K. Depressive symptoms among pregnant women screening in obstetrics settings. J Womens Health. 2003;12(4):373–80.

    Google Scholar 

  47. Milgrom J, Gemmill AW, Bilszta JL, Hayes B, Barnett B, Brooks J, et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord. 2008;108(1–2):147–57.

    PubMed  Google Scholar 

  48. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50(5):278–85.

    Google Scholar 

  49. Marcus SM, Flynn HA, Young E, Ghaziuddin N, Mudd S. Recurrent depression in women through the lifespan. In: Riba M, Oldham J, editors. American psychiatric press review of psychiatry. Washington, DC: American Psychiatric Press, Inc.; 2001. p. 19–50.

    Google Scholar 

  50. Silverman JG, Raj A, Mucci LA, Hathaway JE. Dating violence against adolescent girls and associated substance use, unhealthy weight control, sexual risk behavior, pregnancy, and suicidality. JAMA. 2001;286:572–9.

    CAS  PubMed  Google Scholar 

  51. Wittchen H, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:355–64.

    CAS  PubMed  Google Scholar 

  52. Moller SE. Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression. Neuropsychobiology. 1981;7:192–200.

    CAS  PubMed  Google Scholar 

  53. Parry BL, Rush AJ. Oral contraceptives and depressive symptomatology: biologic mechanisms. Compr Psychiatry. 1979;20:347–58.

    CAS  PubMed  Google Scholar 

  54. Sheenan DV, Sheenan KH. Psychiatric aspects of oral contraceptive use. Psychiatr Ann. 1976;6:500–8.

    Google Scholar 

  55. Winston F. Oral contraceptives, pyridoxine and depression. Am J Psychiatry. 1973;130:1217–21.

    CAS  PubMed  Google Scholar 

  56. Robinson SA, Dowell M, Pedulla D, McCauley L. Do the emotional side-effects of hormonal contraceptives come from pharmacologic or psychological mechanisms? Med Hypotheses. 2004;63:268–73.

    CAS  PubMed  Google Scholar 

  57. CDC. U.S. Medical eligibility criteria for contraceptive use, 2010. MMWR. 2010;59.

    Google Scholar 

  58. Vessey MP, McPherson K, Lawless M, Yeates D. Oral contraception and serious psychiatric illness: absence of an association. Br J Psychiatry. 1985;146:45–9.

    CAS  PubMed  Google Scholar 

  59. Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women? Contraception. 2007;75:27–31.

    CAS  PubMed  Google Scholar 

  60. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: a controlled study. Psychosom Med. 1990;52:86–96.

    CAS  PubMed  Google Scholar 

  61. O’Connell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception. 2007;75:299–304.

    PubMed  Google Scholar 

  62. Deijen JB, Duyn KJ, Jansen WA, Klittsie JW. Use of a monophasic low-dose oral contraceptive in relation to mental functioning. Contraception. 1992;46:359–67.

    CAS  PubMed  Google Scholar 

  63. Almagor M, Ben-Porath MS. Mood changes during the menstrual cycle and their relation to the use of oral contraceptives. J Psychosom Res. 1991;35:721–8.

    CAS  PubMed  Google Scholar 

  64. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and wellbeing and their relationship to discontinuation. Contraception. 2001;64:51–8.

    CAS  PubMed  Google Scholar 

  65. Segebladh B, Borgstrom A, Odlind V, Bixo M, Sundstrom-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009;79:50–5.

    CAS  PubMed  Google Scholar 

  66. Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, et al. Depressive symptoms and depo-provera. Contraception. 1998;57:237–40.

    CAS  PubMed  Google Scholar 

  67. Gupta N, O’Brien R, Jacobsen LJ, Davis A, Zuckerman A, Supran S, et al. Mood changes in adolescents using depo-medroxyprogesterone acetate for contraception. J Pediatr Adolesc Gynecol. 2001;14:71–6.

    CAS  PubMed  Google Scholar 

  68. Tsai S. Effect of depot medroxyprogesterone acetate on postpartum depression. Contraception. 2010;82:174–7.

    CAS  PubMed  Google Scholar 

  69. Westhoff C, Truman C, Kalmuss D, Cushman L, Rulin M, Heartwell S, et al. Depressive symptoms and Norplant contraceptive implants. Contraception. 1998;57(4):241–5.

    CAS  PubMed  Google Scholar 

  70. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2010;17(3)pub3.

    Google Scholar 

  71. Sucato GS, Land SR, Murray PJ, Cecchini R, Gold MA. Adolescents experiences using the contraceptive patch versus pills. J Pediatr Adolesc Gynecol. 2011;24:197–203.

    PubMed  Google Scholar 

  72. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13:13–28.

    CAS  PubMed  Google Scholar 

  73. Elovainio M, Teperi J, Aalto AM, Grenman S, Kivelä A, Kujansuu E, et al. Depressive symptoms as a predictor of discontinuation of treatment of menorrhagia by levoenorgesterol releasing intrauterine system. Int J Behav Med. 2007;14:70–5.

    PubMed  Google Scholar 

  74. Westhoff C, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol. 2007;196:412e1–7.

    Google Scholar 

  75. Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med. 1995;40:355–60.

    CAS  PubMed  Google Scholar 

  76. Stenchever MA, Herbst AL, Droegemueller W, Mishell D, editors. Comprehensive gynecology. St. Louis: Elsevier Health Sciences; 2001.

    Google Scholar 

  77. Hall K, Reame N, O’Connell K, Rickert V, Weshoff C. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012;86:518–25.

    PubMed Central  PubMed  Google Scholar 

  78. Rubino-Watkins MF, Doster JA, Franks S, Kelly KS, Sonnier BL, Goven AJ, et al. Oral contraceptive use: implications for cognitive and emotional functioning. J Nerv Ment Dis. 1999;187:275–80.

    CAS  PubMed  Google Scholar 

  79. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the Nocebo phenomenon. JAMA. 2002;287:22–7.

    Google Scholar 

  80. Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: a spectrum of severity. Am J Psychiatry. 1991;148:34–40.

    CAS  PubMed  Google Scholar 

  81. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol. 2005;1:167–95.

    PubMed  Google Scholar 

  82. Beck AT. Cognitive models of depression. J Cognit Psychother. 1987;1(1):5–37.

    Google Scholar 

  83. Maner JK, Schmidt NB. The role of risk avoidance in anxiety. Behav Ther. 2006;37(2):181–9.

    PubMed  Google Scholar 

  84. Yuen KSL, Lee TMC. Could mood state affect risk-taking decisions? J Affect Disord. 2003;75(1):11–8.

    PubMed  Google Scholar 

  85. Ruscher S, de Wit R, Mazimanian D. Psychiatric patients’ attitudes about medication and factors affecting noncompliance. Psychiatr Serv. 1997;48:82–5.

    CAS  PubMed  Google Scholar 

  86. Patel MS, David AS. Medication adherence: predictive factors and enhancement strategies. Psychiatry. 2004;3:41–4.

    Google Scholar 

  87. Calev A. Assessment of neuropsychological functions in psychotic disorders. Washington, DC: American Psychiatric Press; 1999.

    Google Scholar 

  88. Alvy LM, McKirnan DJ, Mansergh G, Koblin B, Colfax GN, Flores SA, et al. Project MIX Study Group. Depression is associated with sexual risk among men who have sex with men, but is mediated by cognitive escape and self-efficacy. AIDS Behav. 2011;15(6):1171–9.

    Google Scholar 

  89. Clery-Melin ML, Schmidt L, Lafargue G, Baup N, Fossati P, Pessiglione M. Why don’t you try harder? An investigation of effort production in major depression. PLoS One. 2011;6(7):e23178. 1–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  90. Hartley CA, Phelps EA. Anxiety and decision-making. Biol Psychiatr. 2012;72(2):113–8.

    Google Scholar 

  91. Lehrer JA, Shrier LA, Gortmaker S, Buka S. Depressive symptoms as longitudinal predictors of sexual risk behaviors among US middle and high school students. Pediatrics. 2006;118:189–200.

    PubMed  Google Scholar 

  92. Shrier LA, Harris SK, Sternberg M, Beardslee WR. Associations of depression, self-esteem, and substance use with sexual risk among adolescents. Prev Med. 2001;33(3):179–89.

    CAS  PubMed  Google Scholar 

  93. Chen YW, Stiffman AR, Cheng LC, Dore P. Mental health, social environment and sexual risk behaviors of adolescent service users: a gender comparison. J Child Fam Stud. 1997;6:9–25.

    Google Scholar 

  94. Garbers S, Correa N, Tobier N, Blust S, Chiasson MA. Associations between symptoms of depression and contraceptive method choices among low-income women at urban reproductive health centers. Matern Child Health J. 2010;14:102–9.

    PubMed  Google Scholar 

  95. Hall K, Moreau C, Trussell J, Barber J. Role of young women’s depression and stress symptoms in their weekly use and nonuse of contraceptive methods. J Adolesc Health. 2013;53(2):241–8.

    PubMed Central  PubMed  Google Scholar 

  96. Hall K, Moreau C, Trussell J, Barber J. Young women’s consistency of contraceptive use—do depression and stress matter? Contraception. 2013;88(5):641–9.

    Google Scholar 

  97. Brooks TL, Harris SK, Thrall JS. Woods ER Association of adolescent risk behaviors with mental health symptoms in high school students. J Adolesc Health. 2002;31:240–6.

    PubMed  Google Scholar 

  98. Zink TM, Shireman TI, Ho M, Buchanan T. High-risk teen compliance with prescription contraception: an analysis of Ohio medicaid claims. J Pediatr Adolesc Gynecol. 2002;15:15–21.

    PubMed  Google Scholar 

  99. Steinberg JR, Tschann JM, Henderson JT, Drey EA, Steinauer JE, Harper CC. Psychological distress and post-abortion contraceptive choice at an urban clinic. Contraception. 2013;88:717–24.

    PubMed  Google Scholar 

  100. Mann JJ. The medical management of depression. N Engl J Med. 2005;353:1819–34.

    CAS  PubMed  Google Scholar 

  101. Roter DL, Frankel RM, Hall JA, Sluyter D. The expression of emotion through nonverbal behavior in medical visits. Mechanisms and outcomes. J Gen Intern Med. 2006;21:s28–34.

    PubMed Central  PubMed  Google Scholar 

  102. Hackley B, Sharma C, Kedzior A, Sreenivasan S. Managing mental health conditions in primary care settings. J Midwifery Womens Health. 2010;55(1):9–19.

    PubMed  Google Scholar 

  103. National Institute for Health and Clinical Excellence Clinical guidelines CG90, TMAP Guidelines, The MacArthur Initiative on Depression and Primary Care. 2009.

    Google Scholar 

  104. University of Michigan Depression Center Toolkit [internet]. http://depressiontoolkit.org/treatmentoptions/Psychotherapy/dbt.asp. Accessed 20 Dec 2012.

  105. ARHP’s Clinical Advisory Committee for The Reproductive Health Implications of Depression [internet]. 2011. http://www.arhp.org/core. Accessed 1 Feb 2013.

  106. American Psychological Association [internet]. Assessment tools. http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/index.aspx. Accessed 1 Feb 2013.

  107. Bohannon RW, Maljanian R, Goethe J. Screening for depression in clinical practice: reliability and validity of a five-item subset of the CES-depression. Percept Mot Skills. 2003;97:855–61.

    PubMed  Google Scholar 

  108. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1993;24:385–96.

    Google Scholar 

  109. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.

    Google Scholar 

  110. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;12(14):1905–7.

    Google Scholar 

  111. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92.

    PubMed  Google Scholar 

  112. Cotton MA, Ball C, Robinson P. Four simple questions can help screen for eating disorders. J Gen Intern Med. 2003;18:53–6.

    PubMed Central  PubMed  Google Scholar 

  113. McDowell AK, Lineberry TW, Bostwick JM. Practical suicide-risk management for the busy primary care physician. Mayo Clin Proc. 2011;86:792–800.

    PubMed Central  PubMed  Google Scholar 

  114. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77–84.

    CAS  PubMed  Google Scholar 

  115. Spitzer RL, Kroenke K, Williams JBW, Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737–44.

    CAS  PubMed  Google Scholar 

  116. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the beck depression inventory: a review. Psychopathology. 1998;31(3):160–8.

    CAS  PubMed  Google Scholar 

  117. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–43.

    CAS  PubMed  Google Scholar 

  118. Fydrich T, Dowdall D, Chambless DL. Reliability and validity of the beck anxiety inventory. J Anxiety Dis. 1992;6(1):55–61.

    Google Scholar 

  119. Beck AT, Steer RA. Manual for the beck anxiety inventory. San Antonio, TX: Psychological Corporation; 1990.

    Google Scholar 

  120. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. State-trait anxiety inventory for adults: manual, test booklet and scoring key 1983. Palo Alto, CA: Consulting Psychologist Press, Inc.; 1983.

    Google Scholar 

  121. Higgins ES. A review of unrecognized mental illness in primary care prevalence, natural history and efforts to change the course. Arch Fam Med. 1994;3:908–17.

    CAS  PubMed  Google Scholar 

  122. Koke SC, Brown EB, Miner CM. Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy. Am J Obstet Gynecol. 2002;187:551–5.

    CAS  PubMed  Google Scholar 

  123. D’Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm. 1986;20:353–62.

    PubMed  Google Scholar 

  124. Anderson IM, Edwards JG. Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness. Adv Psychiatr Treat. 2001;7:170–80.

    Google Scholar 

  125. Buckley P, editor. Sexuality and serious mental illness. Netherlands: Harwood Academic Publishers; 2013.

    Google Scholar 

  126. Will-Shahab L, Bauer S, Kunter U, Roots I, Brattstrom A. St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low dose oral contraceptive. Eur J Clin Pharmacol. 2009;65:287–94.

    PubMed  Google Scholar 

  127. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John’s wort with oral contraceptives; effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception. 2005;71:402–8.

    CAS  PubMed  Google Scholar 

  128. Hatcher RA, Trussell J, Stewart F, et al. Contraceptive technology. 20 (Revised)th ed. New York, NY: Ardent Media; 2004.

    Google Scholar 

  129. Hunot VM, Caldwell D, Jones DP, Furukawa TA, Lewis G, Churchhill R. Cognitive behavioural therapies versus treatment as usual for depression. Cochrane Database Syst Rev. 2010; DOI: 10.1002/14651858.CD008699.

    Google Scholar 

  130. Hunot V, Churchill R, Teixeira V, Silva de Lima M. Psychological therapies for generalised anxiety disorder. Cochrane Data Syst Rev. 2007;1, Art. No.: CD001848. DOI:10.1002/14651858

  131. Churchill R, Davies P, Caldwell D, Moore THM, Jones H, Lewis G, Hunot V. Interpersonal, cognitive analytic and other integrative therapies versus treatment as usual for depression. Cochrane Database Syst Rev. 2010;9, Art. No.: CD008703. DOI:10.1002/14651858.CD008703.

  132. Hall KS, Reame N, O’Connell K, Westhoff C. Studying the use of oral contraception: a review of measurement approaches. J Womens Health. 2010;19:2203–10.

    Google Scholar 

  133. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.

    CAS  PubMed  Google Scholar 

  134. Osterberg L, Blascke T. Adherence to medication. N Engl J Med. 2005;353:487–97.

    CAS  PubMed  Google Scholar 

  135. World Health Organization (WHO) Department of Reproductive Health and Research, Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP). Knowledge for health project. Family planning: a global handbook for providers (2011 update). Baltimore, MD; Geneva, Switzerland: CCP and WHO; 2011.

    Google Scholar 

  136. Trussell J, Vaughn B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 NSFG. Fam Plann Perspect. 1999;31:64–72. 93.

    CAS  PubMed  Google Scholar 

  137. Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital Health Stat. 2010;23:1–43.

    Google Scholar 

  138. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception. 2008;77:10–21.

    PubMed Central  PubMed  Google Scholar 

  139. Moreau C, Trussell J, Gilbert F, Bajos N, Bouyer J. Oral contraceptive tolerance: does the type of pill matter? Obstet Gynecol. 2007;109:1277–85.

    CAS  PubMed  Google Scholar 

  140. Hall KS, Trussell J. Types of combined oral contraceptives used by US women. Contraception. 2012;86(6):659–65.

    PubMed Central  PubMed  Google Scholar 

  141. Gallo MF, Grimes NK, Lopez LM, Schulz KF. 20ug versus >20ug estrogen combined oral contraceptives for contraception. Cochrane Collab Rev. 2011;1. http://www.thecochranelibrary.com.

  142. Maitra NN, Kulier R, Bloemenkamp K, Helmerhorst FM, Gulmezogul AM. Progestogens in combined oral contraceptives for contraception. Cochrane Collab Rev. 2011;3. http://www.thecochranelibrary.com.

  143. Lawrie TA, Helmerhorst FM, Maitra NN, Kulier R, Bloemenkamp K, Gulmezoglu AM. Types of progestogens in combined oral contraception: effectiveness and side-effects Cochrane Collab Rev. 2011;5. http://www.thecochranelibrary.com.

  144. Van Vliet HAAM, Grimes DA, Lopez LM, Schulz KF, Helmerhorst FM. Triphasic versus monophasic oral contraceptives for contraception. Cochrane Collab Rev. 2011;12. http://www.thecochranelibrary.com.

  145. Edelman A, Gallo MF, Jensen JT, Nichols MD, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Collab Rev. 2011;8. http://www.thecochranelibrary.com.

  146. Ward RK, Zamorski MA. Benefits and risks of psychiatric medication during pregnancy. Am Fan Physician. 2002;66:629–36.

    Google Scholar 

  147. Flynn HA, O'Mahen HA, Massey L, Marcus S. The impact of a brief obstetrics clinic-based intervention on treatment use for perinatal depression. J Womens Health. 2006;15:1195–204.

    Google Scholar 

  148. Marcus SM, Barry KL, Flynn HA, Tandon R, Greden JF. Treatment guidelines for depression in pregnancy. Int J Gynecol Obstet. 2001;72:61–70.

    CAS  Google Scholar 

  149. O’Mahen HA, Himle JA, Fedock G, Henshaw E, Flynn HA. A pilot randomized controlled trial of cognitive behavioral therapy for perinatal depression adapted for women with low incomes. Depress Anxiety. 2013;30(7):679–87.

    PubMed  Google Scholar 

  150. Freeman EW, Samuel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375–82.

    CAS  PubMed  Google Scholar 

  151. Parry BL. Optimal management of perimenopausal depression. Int J Womens Health. 2010;2:143–51.

    CAS  PubMed Central  PubMed  Google Scholar 

  152. Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, et al. A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry. 2008;69(6):973–80.

    PubMed Central  PubMed  Google Scholar 

  153. Frost JJ, Lindberg LD, Finer LB. Young adults’ contraceptive knowledge, norms and attitudes: associations with risk of unintended pregnancy. Perspect Sex Reprod Health. 2012;44(2):107–16.

    PubMed  Google Scholar 

  154. Hall KS, Castano P, Stone P, Westhoff C. Measuring oral contraceptive knowledge: a review of research findings and limitations. Patient Educ Couns. 2010;81:388–94.

    PubMed Central  PubMed  Google Scholar 

  155. Akers AY, Gold MA, Borrero S, Santucci A, Schwarz EB. Structured contraceptive counseling—a randomized controlled trial. J Womens Health. 2010;19:1163–70.

    Google Scholar 

  156. Hall K. The health belief model can guide modern contraceptive research. J Midwifery Womens Health. 2011;57:74–81.

    PubMed Central  PubMed  Google Scholar 

  157. Lopez LM, Tolley EE, Grimes DA, Mario CM. Theory-based strategies for improving contraceptive use: a systematic review. Contraception. 2009;79:411–7.

    PubMed  Google Scholar 

  158. Tessler SL, Peipert JF. Perceptions of contraceptive effectiveness and health effects of oral contraception. Womens Health Issues. 1997;7:400–6.

    CAS  PubMed  Google Scholar 

  159. Rickert VI, Berenson AB, Williamson AJ, Wiemann CM. Immediate recall of oral contraceptive instructions: implications for providers. Am J Obstet Gynecol. 1999;180:1399–406.

    CAS  PubMed  Google Scholar 

  160. Grimes DA, Schulz KF. Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception. 2011;83(1):5–9.

    CAS  PubMed  Google Scholar 

  161. ACOG. Intimate partner violence. Committee Opinion No. 518. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012;119:412–7.

    Google Scholar 

  162. Black MC, Basile KC, Breidig MJ, Smith SG, Walters ML, Merrick MT, et al. The National Intimate Partner and Sexual Violence Survey (NISVS): 2010 summary report. Atlanta (GA): National Center for Injury Prevention and Control, Centers for Disease Control and Prevention; 2011.

    Google Scholar 

  163. Lehrer JA, Buka B, Gortmaker S, Shrier LA. Depressive symptomatology as a predictor of exposure to intimate partner violence among US female adolescents and young adults. Arch Pediatr Adolesc Med. 2006;160(3):270–6.

    PubMed  Google Scholar 

  164. National Alliance on Mental Illness [internet]. About mental illness. http://www.nami.org/template.cfm?section=about_mental_illness. Accessed 2 June 2013

  165. National Institute of Mental Health [internet]. Prevalence of serious mental illness among U.S. Adults by age, sex and race. http://www.nimh.nih.gov/statistics/SMI_AASR.shtml. Accessed 20 Aug 2013.

  166. Matevosyan NR. Reproductive health in women with serious mental illnesses: a review. Sex Disabil. 2009;27:109–18.

    Google Scholar 

  167. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizopr Bull. 1997;23(4):623–35.

    CAS  Google Scholar 

  168. Miller LJ, Finnerty M. Family planning knowledge, attitudes and practices in women with schizophrenic spectrum disorders. J Psychosom Obstet Gynaecol. 1998;19:210–7.

    CAS  PubMed  Google Scholar 

  169. Krumm S, Killan R, Becker T. Mentally ill women’s subjective views on social context of desire for children. A qualitative approach. Psychiatr Prax. 2011;38(1):23–30.

    PubMed  Google Scholar 

  170. Guedes TG, Moura ERF, Almeida PC. Particularities of family planning in women with mental disorders. Rev Lat Am Enfermagem. 2009;17(5):639–44.

    PubMed  Google Scholar 

  171. Seeman MV, Ross R. Prescribing contraceptives for women with schizophrenia. J Psychiatr Pract. 2011;17:258–69.

    PubMed  Google Scholar 

  172. McCullough LB, Coverdale J, Bayer T, Chernenak FA. Ethically justified guidelines for family planning interventions to prevent pregnancy in female patients with chronic mental illness. Am J Obstet Gynecol. 1992;167:19–25.

    CAS  PubMed  Google Scholar 

  173. Coverdale JH, Bayer TL, McCullough LB, Chervenak FA. Respecting the autonomy of chronic mentally ill women in decisions about contraception. Hosp Community Psychiatry. 1993;44(7):671–4.

    CAS  PubMed  Google Scholar 

  174. Magalhaes PVS, Kapczinkski F, Kauer-Sant’Anna M. Use of contraceptive methods among women treated for bipolar disorder. Arch Womens Ment Health. 2009;12:183–5.

    PubMed  Google Scholar 

  175. Lang DL, Sales JM, Salazar LR, DiClemente RJ, Crosby RA, Brown LK, et al. Determinants of multimethod contraceptive use in a sample of adolescent women diagnosed with psychological disorders. Infect Dis Obstet Gynecol. 2000;2011:1–8.

    Google Scholar 

  176. Berenson AB, Asem H, Tan A, Wilkinson GS. Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder. Obstet Gynecol. 2011;118(6):1331–6.

    PubMed Central  PubMed  Google Scholar 

  177. Whitmore EA, Mikulich SK, Ehlers KM, Crowley TJ. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug Alcohol Depend. 2000;59(2):131–41.

    CAS  PubMed  Google Scholar 

  178. Smith MD. HIV risk in adolescents with severe mental illness: literature review. J Adolesc Health. 2001;29(5):320–9.

    CAS  PubMed  Google Scholar 

  179. Auslander WF, McMillen JC, Elze D, Thompson R, Jonson-Reid M, Stiffman A. Mental health problems and sexual abuse among adolescents in foster care: relationship to HIV risk behaviors and intentions. AIDS Behav. 2002;6(4):351–9.

    Google Scholar 

  180. Tubman JG, Gil AG, Wagner EF, Artigues H. Patterns of sexual risk behaviors and psychiatric disorders in a community sample of young adults. J Behav Med. 2003;26(5):473–500.

    PubMed  Google Scholar 

  181. DiClemente RJ, Ponton LE. HIV-related risk behaviors among psychiatrically hospitalized adolescents and school- based adolescents. Am J Psychiatry. 1993;150(2):324–5.

    CAS  PubMed  Google Scholar 

  182. Haboubi NH, Lincoln N. Views of health professionals on discussing sexual issues with patients. Disabil Rehabil. 2003;25:291–6.

    CAS  PubMed  Google Scholar 

  183. Wright ER, Wright DE, Perry BL, Foote-Ardah CE. Stigma and the sexual isolation of people with serious mental illness. Soc Prob. 2007;54:78–98.

    Google Scholar 

  184. Abel K, Rees S. Reproductive and sexual health of women service users: what’s the fuss? Adv Psychiatr Treat. 2010;16:279–80.

    Google Scholar 

  185. Cropsey KL, Matthews C, Campbel S, Ivey S, Adawadkar S. Long-term, reversible contraception use among high-risk women treated in a university-based gynecology clinic: comparison between IUD and depo-provera. J Womens Health (Larchmt). 2010;19:349–53.

    Google Scholar 

  186. Verhaeghe J. Hormonal contraception in women with the metabolic syndrome: a narrative review. Eur J Contracept Reprod Health Care. 2010;15:305–13.

    PubMed  Google Scholar 

  187. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs. 2002;16:263–72.

    CAS  PubMed  Google Scholar 

  188. Dutton C, Foldvary-Schaefer N. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management. Int Rev Neurobiol. 2008;83:113–34.

    PubMed  Google Scholar 

  189. Seeman MV. Antipsychotic-induced amenorrhea. J Ment Health. 2011;20(5):484–91.

    PubMed  Google Scholar 

  190. Richer-Rossler A, Schmid C, Bleuer S, Birkhauser M. Antipsychotics and hyperprolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy. Neuropsychiatr. 2009;23(2):71–83.

    Google Scholar 

  191. Riecher-Rössler A. Oestrogen effects in schizophrenia and their potential therapeutic implications—review. Arch Womens Ment Health. 2002;5(3):111–8.

    PubMed  Google Scholar 

  192. Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry. 2008;65:955–60.

    PubMed  Google Scholar 

  193. Riecher-Rössler A, de Geyter C. The forthcoming role of treatment with oestrogens in mental health. Swiss Med Wkly. 2007;137:565–72.

    PubMed  Google Scholar 

  194. Currier GW, Simpson GM. Psychopharmacology: antipsychotic medications and fertility. Psychiatr Serv. 1998;49:175–6.

    CAS  PubMed  Google Scholar 

  195. Gaffield ME, Culwell KR, Lee CR. The use of hormonal contraception among women taking anticonvulsant therapy. Contraception. 2011;83:16–29.

    CAS  PubMed  Google Scholar 

  196. Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet. 1996;31:198–214.

    CAS  PubMed  Google Scholar 

  197. Herzog AG, Blum AS, Farina EL, Maestri XE, Newman J, Garcia E, et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology. 2009;72:911–4.

    CAS  PubMed  Google Scholar 

  198. Wegner I, Edelbroek PM, Bulk S, Lindhout D. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives. Neurology. 2009;73:1388–93.

    CAS  PubMed  Google Scholar 

  199. Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet. 2004;43:763–80.

    CAS  PubMed  Google Scholar 

  200. Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother. 2010;10:119–40.

    CAS  PubMed  Google Scholar 

  201. Reddy DS. Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol. 2010;3:183–92.

    CAS  PubMed Central  PubMed  Google Scholar 

  202. Gabbay V, O’Dowd MA, Mamamtavrishvili M, Asnis GM. Clozapine and oral contraceptives: a possible drug interaction. J Clin Psychopharmacol. 2002;22:621–2.

    CAS  PubMed  Google Scholar 

  203. Brown D, Goosen TC, Chetty M, Hamman JH. Effect of oral contraceptives on the transport of chlorpromazine across the CACO-2 intestinal epithelial cell line. Eur J Pharm Biopharm. 2003;56:159–65.

    CAS  PubMed  Google Scholar 

  204. Chetty M, Miller R. Oral contraceptives increase the plasma concentrations of chlorpromazine. Ther Drug Monit. 2001;23:556–8.

    CAS  PubMed  Google Scholar 

  205. World Health Organization. Mental Health Aspects of Women’s Reproductive Health: A global review of the literature. Geneva, Switzerland:WHO; 2009.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA

    Kelli Stidham Hall Ph.D., M.S.

  2. Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA

    Julia R. Steinberg Ph.D., M.A.

  3. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA

    Sheila M. Marcus M.D.

Authors
  1. Kelli Stidham Hall Ph.D., M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia R. Steinberg Ph.D., M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sheila M. Marcus M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelli Stidham Hall Ph.D., M.S. .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

    Rebecca H. Allen

  2. Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA

    Carrie A. Cwiak

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hall, K.S., Steinberg, J.R., Marcus, S.M. (2014). Contraception for Women with Mental Health Conditions. In: Allen, R., Cwiak, C. (eds) Contraception for the Medically Challenging Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1233-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1233-9_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1232-2

  • Online ISBN: 978-1-4939-1233-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation